Bioporto AS (OCSE:BIOPOR) FFO


OCSE:BIOPOR Bioporto AS OCSE:BIOPOR
66 GF Score
Price kr1.10
GF Value kr1.24
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bioporto AS FFO?

FFO (Funds from operations) only applies to REITs.

OCSE:BIOPOR
66GF Score
Bioporto AS OCSE:BIOPOR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioporto AS (OCSE:BIOPOR) Overvalued in 2026?

Based on GuruFocus' analysis, Bioporto AS stock appears to be undervalued. The current stock price of kr1.10 is trading 11.3% below its estimated GF Value™ of kr1.24. GuruFocus considers Bioporto AS to be Modestly Undervalued.

Key valuation signals for OCSE:BIOPOR:

  • FFO:
  • GF Value™: kr1.24 vs. price of kr1.10 (11.3% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the OCSE:BIOPOR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioporto AS Business Description

Address Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.
66GF Score

Get the complete analysis for OCSE:BIOPOR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.10
Price
kr1.24
GF Value